Skip to content
BY 4.0 license Open Access Published by De Gruyter March 9, 2020

Clinical efficacy of 5-hydroxytryptamine 3 receptor antagonists in reducing propofol injection pain, postoperative nausea/vomiting and shivering: A meta-analysis

  • Wenjie Zhou and Jie Zhou EMAIL logo
From the journal Pteridines

Abstract

Objective To investigate the clinical efficacy of 5-hydroxytryptamine 3 (5-HT3) receptor antagonists in reducing propofol injection pain, postoperative nausea/ vomiting, and shivering through pooling the available published data.

Methods Prospective randomized clinical studies relevant to 5-HT3 receptor antagonists in reducing propofol injection pain published before June 2019 were identified from four electronic databases, Pubmed, the Cochrane central register of controlled trials, EMBASE and Wanfang. The incidence of propofol injection pain, postoperative nausea/vomiting, and shivering in patients after 5-HT3 receptor antagonists were compared to relevant control groups by pooling the individual data through random or fixed-effect models. The publication bias was assessed by funnel plot and Egger’s line regression test.

Results After screening, a total of 19 publications relevant to 5-HT3 receptor antagonists in reducing propofol injection pain and prevention of postoperative nausea/vomiting or shivering were included for analysis. The pooled results demonstrated that 5-HT3 receptor antagonists could significantly reduce the total propofol injection pain compared to placebo (RR=0.49, 95%CI:0.45-0.54, P<0.05). For mild propofol injection pain, there was no statistical difference between 5-HT3 receptor antagonists and control groups (RR=1.07,95%CI:0.89-1.29, P>0.05). However, for moderate (RR=0.37, 95%CI: 0.31-0.46, P<0.05) and severe (RR=0.19, 95%CI:0.14-0.27, P<0.05) propofol injection pain, the incidence in 5-HT3 receptor antagonists was significantly lower than that of control groups. The pooled results also indicated that incidence of postoperative nausea/vomiting (RR=0.28, 95%CI:0.17-0.44, P<0.05) and postoperative shivering (RR=0.33, 95%CI:0.23-0.48, P<0.05) were significantly reduced in 5-HT3 receptor antagonists group compared to control group with a statistical difference.

Conclusion: In this meta-analysis, 5-HT3 receptor antagonists effectively reduced propofol injection pain, postoperative nausea/vomiting, and shivering.

References

1. Agarwal A, Ansari MF, Gupta D, Pandey R, Raza M, Singh PK, et al. Pretreatment with thiopental for prevention of pain associated with propofol injection. Anesth Analg. 2004 Mar;98(3):683–6.10.1213/01.ANE.0000103266.73568.18Search in Google Scholar PubMed

2. Desousa KA. Pain on propofol injection: causes and remedies. Indian J Pharmacol. 2016 Nov-Dec;48(6):617–23.10.4103/0253-7613.194845Search in Google Scholar PubMed PubMed Central

3. Auerswald K, Pfeiffer F, Behrends K, Burkhardt U, Olthoff D. [Pain on injection with propofol]. Anasthesiol Intensivmed Notfallmed Schmerzther. 2005 May;40(5):259–66.10.1055/s-2005-861353Search in Google Scholar PubMed

4. Tan CH, Onsiong MK. Pain on injection of propofol. Anaesthesia. 1998 May;53(5):468–76.10.1046/j.1365-2044.1998.00405.xSearch in Google Scholar PubMed

5. Eberhart LH, Morin AM, Bothner U, Georgieff M. Droperidol and 5-HT3-receptor antagonists, alone or in combination, for prophylaxis of postoperative nausea and vomiting. A meta-analysis of randomised controlled trials. Acta Anaesthesiol Scand. 2000 Nov;44(10):1252–7.10.1034/j.1399-6576.2000.441011.xSearch in Google Scholar PubMed

6. Loewen PS, Marra CA, Zed PJ. 5-HT3 receptor antagonists vs traditional agents for the prophylaxis of postoperative nausea and vomiting. Can J Anaesth. 2000 Oct;47(10):1008–18.10.1007/BF03024875Search in Google Scholar PubMed

7. Qimin L, Jianmin Z, Xiaoyin Z, Lidan X. Clinical study of Ondansetron Combined with Low Dose Sufentanil in Preventing Injection Pain of Propofol. Strait Pharmaceutical Journal; 2011. pp. 114–5.Search in Google Scholar

8. Ming Z. A comparative study of ondansetron and lidocaine in the prevention of propofol injection pain. Shanxi Medical Journal; 2012. pp. 263–5.Search in Google Scholar

9. Zafarmand MH, van der Schouw YT, Grobbee DE, de Leeuw PW, Bots ML. The M235T polymorphism in the AGT gene and CHD risk: evidence of a Hardy-Weinberg equilibrium violation and publication bias in a meta-analysis. PLoS One. 2008 Jun;3(6):e2533.10.1371/journal.pone.0002533Search in Google Scholar PubMed PubMed Central

10. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986 Sep;7(3):177–88.10.1016/0197-2456(86)90046-2Search in Google Scholar PubMed

11. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003 Sep;327(7414):557–60.10.1136/bmj.327.7414.557Search in Google Scholar PubMed PubMed Central

12. Ambesh SP, Dubey PK, Sinha PK. Ondansetron pretreatment to alleviate pain on propofol injection: a randomized, controlled, double-blinded study. Anesth Analg. 1999 Jul;89(1):197–9.10.1213/00000539-199907000-00035Search in Google Scholar

13. Dubey PK, Prasad SS. Pain on injection of propofol: the effect of granisetron pretreatment. Clin J Pain. 2003 Mar-Apr;19(2):121–4.10.1097/00002508-200303000-00007Search in Google Scholar PubMed

14. Cao D, Ding J, Wang M, Zhou Z. Comparison of lidocaine and ondansetron for the prevention of pain on injection of propofol. Xiandai Yiyao Weisheng. 2005:2578–9.Search in Google Scholar

15. Liu F, Ge H, Zhou R. Preventive effect of tropisetron on intravenous pain induced by propofol. Zhongguo Yiyuan Yaoxue Zazhi. 2006:192–3.Search in Google Scholar

16. Ma Y, Lin X, Zhou J. Effects of Granisetron/Lidocaine Combination on Propofol Injection-induced Pain: A Double-blind Randomized Clinical Trial. Journal of Sichuan University 2009:536-538.Search in Google Scholar

17. Fu H. Clinical Efficacy of Granisetron Combined with Lidocaine pretreatment in Minimizing Propofol Injection Pain and Vomiting. China Pharmacy; 2010. pp. 1476–8.Search in Google Scholar

18. Tu X. The Prevention for Injection Pain with Several Method. Hebei Med. 2010:847–9.Search in Google Scholar

19. Singh DK, Jindal P, Singh G. Comparative study of attenuation of the pain caused by propofol intravenous injection, by granisetron, magnesium sulfate and nitroglycerine. Saudi J Anaesth. 2011 Jan;5(1):50–4.10.4103/1658-354X.76511Search in Google Scholar PubMed PubMed Central

20. Shao L, Lv H, Tian A, Liu Y, Wu Q. Effect of Combination of Tropisetron and Lidocaine on Propofol Injection induced Pain. Chinese Journal of Hemorheology. 2011;284-286:336.Search in Google Scholar

21. Yan Y, Mou Z, Wu Z. Prevention and treatment of propofol injection pain by hypothermia, ondansetron and lidocaine alone or in combination. Chinese Community Doctors; 2011. p. 175.Search in Google Scholar

22. Lu H. Preventive effect of intravenous ondansetron on propofol injection pain. Journal of Mudanjiang Medical University 2011:39-40.Search in Google Scholar

23. Zahedi H, Maleki A, Rostami G. Ondansetron pretreatment reduces pain on injection of propofol. Acta Med Iran. 2012;50(4):239–43.Search in Google Scholar

24. Ahmed A, Sengupta S, Das T, Rudra A, Iqbal A. Pre-treatment with intravenous granisetron to alleviate pain on propofol injection: A double-blind, randomized, controlled trial. Indian J Anaesth. 2012 Mar;56(2):135–8.10.4103/0019-5049.96308Search in Google Scholar PubMed PubMed Central

25. Ryu HB, Kim SJ. Analgesic effects of palonosetron in the intravenous propofol injection. Korean J Anesthesiol. 2014 Feb;66(2):99–104.10.4097/kjae.2014.66.2.99Search in Google Scholar PubMed PubMed Central

26. Lee KH, Rim SK, Lee JY, Lee SY, Lee SN, Lee EJ, et al. Effects of pretreatment with intravenous palonosetron for propofolremifentanil-based anesthesia in breast and thyroid cancer surgery: a double-blind, randomized, controlled study. Korean J Anesthesiol. 2014 Jul;67(1):13–9.10.4097/kjae.2014.67.1.13Search in Google Scholar PubMed PubMed Central

27. Alipour M, Tabari M, Alipour M. Paracetamol, ondansetron, granisetron, magnesium sulfate and lidocaine and reduced propofol injection pain. Iran Red Crescent Med J. 2014 Mar;16(3):e16086.10.5812/ircmj.16086Search in Google Scholar PubMed PubMed Central

28. Singh D, Jagannath S, Priye S, Shivaprakash, Kadli C, Reddy D. Prevention of propofol injection pain: comparison between lidocaine and ramosetron. J Anaesthesiol Clin Pharmacol. 2014 Apr;30(2):213–6.10.4103/0970-9185.130023Search in Google Scholar PubMed PubMed Central

29. Wang W, Wu L, Zhang C, Sun L. Is propofol injection pain really important to patients? BMC Anesthesiol. 2017 Feb;17(1):24.10.1186/s12871-017-0321-7Search in Google Scholar PubMed PubMed Central

30. Lee JH, Jung SY, Kim MH, Cho K. The effect of dexmedetomidine on propofol injection pain. Korean J Anesthesiol. 2014 Dec;67 Suppl:S30–1.10.4097/kjae.2014.67.S.S30Search in Google Scholar PubMed PubMed Central

31. Singh PM, Borle A, Panwar R, Makkar JK, McGrath I, Trikha A, et al. Perioperative antiemetic efficacy of dexamethasone versus 5-HT3 receptor antagonists: a meta-analysis and trial sequential analysis of randomized controlled trials. Eur J Clin Pharmacol. 2018 Oct;74(10):1201–14.10.1007/s00228-018-2495-4Search in Google Scholar PubMed

32. Kim KI, Lee DE, Cho I, Yoon JH, Yoon SS, Lee HS, et al. Effectiveness of palonosetron versus other serotonin 5-HT3 receptor antagonists in triple antiemetic regimens during multiday highly emetogenic chemotherapy. Ann Pharmacother. 2012 Dec;46(12):1637–44.10.1345/aph.1R396Search in Google Scholar PubMed

33. Gamse R. Antiemetic action of 5-HT3 receptor antagonists: review of preclinical and clinical results with ICS 205-930. Cancer Treat Rev. 1990 Sep;17(2-3):301–5.10.1016/0305-7372(90)90061-JSearch in Google Scholar PubMed

34. Lin SJ, Hatoum HT, Buchner D, Cox D, Balu S. Impact of 5-HT3 receptor antagonists on chemotherapy-induced nausea and vomiting: a retrospective cohort study. BMC Health Serv Res. 2012 Jul;12(1):215.10.1186/1472-6963-12-215Search in Google Scholar PubMed PubMed Central

35. Smith HS, Cox LR, Smith EJ. 5-HT3 receptor antagonists for the treatment of nausea/vomiting. Ann Palliat Med. 2012 Jul;1(2):115–20.Search in Google Scholar

36. Du Q, Zhai Q, Zhu B, Xu XL, Yu B. Economic evaluation of 5-HT3 receptor antagonists in combination with dexamethasone for the prevention of ‘overall’ nausea and vomiting following highly emetogenic chemotherapy in Chinese adult patients. J Oncol Pharm Pract. 2017 Sep;23(6):403–12.10.1177/1078155216652212Search in Google Scholar PubMed

37. Fakhfouri G, Rahimian R, Dyhrfjeld-Johnsen J, Zirak MR, Beaulieu JM. 5-HT3 Receptor Antagonists in Neurologic and Neuropsychiatric Disorders: The Iceberg Still Lies beneath the Surface. Pharmacol Rev. 2019 Jul;71(3):383–412.10.1124/pr.118.015487Search in Google Scholar PubMed

Received: 2019-07-24
Accepted: 2020-01-02
Published Online: 2020-03-09

© 2020 Wenjie Zhou et al., published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Downloaded on 29.3.2024 from https://www.degruyter.com/document/doi/10.1515/pteridines-2020-0003/html
Scroll to top button